scholarly journals Australia’s notifiable disease status, 2015: Annual report of the National Notifiable Diseases Surveillance System

Author(s):  

In 2015, 67 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 320,480 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 16% on the number of notifications in 2014. In 2015, the most frequently notified diseases were vaccine preventable diseases (147,569 notifications, 46% of total notifications), sexually transmissible infections (95,468 notifications, 30% of total notifications), and gastrointestinal diseases (45,326 notifications, 14% of total notifications). There were 17,337 notifications of bloodborne diseases; 12,253 notifications of vectorborne diseases; 1,815 notifications of other bacterial infections; 710 notifications of zoonoses and 2 notifications of quarantinable diseases.

2021 ◽  
Vol 45 ◽  
Author(s):  

In 2016, a total of 67 diseases and conditions were nationally notifiable in Australia. The states and territories reported 330,387 notifications of communicable diseases to the National Notifiable Diseases Surveillance System. Notifications have remained stable between 2015 and 2016. In 2016, the most frequently notified diseases were vaccine preventable diseases (139,687 notifications, 42% of total notifications); sexually transmissible infections (112,714 notifications, 34% of total notifications); and gastrointestinal diseases (49,885 notifications, 15% of total notifications). Additionally, there were 18,595 notifications of bloodborne diseases; 6,760 notifications of vectorborne diseases; 2,020 notifications of other bacterial infections; 725 notifications of zoonoses and one notification of a quarantinable disease.


Author(s):  
Monica M Lahra ◽  
Rodney Enriquez ◽  
Tiffany Hogan ◽  

Invasive meningococcal disease (IMD) is a notifiable disease in Australia, and both probable and laboratory-confirmed cases of IMD are reported to the National Notifiable Diseases Surveillance System (NNDSS). In 2018, there were 281 IMD cases notified to the NNDSS. Of these, 278 were laboratory-confirmed cases analysed by the reference laboratories of the Australian National Neisseria Network (NNN). On investigation, the serogroup was able to be determined for 98.6% (274/278) of laboratory-confirmed cases. Serogroup B infections accounted for 44.2% of cases (123 cases); serogroup W for 36.3% of cases (101 cases); serogroup Y infections for 15.8% (44 cases) and serogroup C 1.4% (4 cases); and there were two unrelated cases (0.7%) of IMD attributable to serogroup E. Using molecular methods, 181/278 IMD cases were able to be typed. Of note was that 89% of typed serogroup W IMD cases (66/74) were porA antigen type P1.5,2; of this number, 44% (29/66) were sequence type 11, the hypervirulent strain reported in recent outbreaks in Australia and overseas. The primary age peak of IMD in Australia in 2018 was again observed in adults aged 45 years or more; a secondary disease peak was observed in children and infants aged less than 5 years. Serogroup B infections predominated in those aged less than 5 years, whereas serogroup W and serogroup Y infections predominated in those aged 45 years or more. Of the IMD isolates tested for antimicrobial susceptibility, 1.4% (3/210) were resistant to penicillin with an MIC ≥ 1 mg/L, and decreased susceptibility to penicillin was observed in a further 93.8% (197/210) of isolates. All isolates were susceptible to ceftriaxone and rifampicin; there was one isolate less susceptible to ciprofloxacin.


2005 ◽  
Vol 133 (3) ◽  
pp. 401-407 ◽  
Author(s):  
A. JANSSON ◽  
M. ARNEBORN ◽  
K. EKDAHL

To assess the sensitivity of the Swedish surveillance system, four notifiable communicable diseases in Sweden were examined during 1998–2002 with the two-sources capture–recapture method, based on parallel clinical and laboratory notifications. The sensitivity (proportion of diagnosed diseases actually being notified) was highest for salmonellosis (99·9%), followed by meningococcal infection (98·7%), and tularaemia (98·5%). For penicillin-resistant pneumococci, introduced as a notifiable disease in 1996, the overall sensitivity was 93·4% – increasing from 86·5% in 1998 to 98·5% in 2002. The system benefited from parallel reporting, with a sensitivity of clinical and laboratory notifications alone (all diseases combined) of 91·6% and 95·9% respectively. The sensitivity of both clinical and laboratory notifications was markedly higher in counties using the national electronic reporting system, SmiNet. Thus, sensitivity was higher for diseases with a long tradition of reporting, and there is a run-in period after a new disease becomes notifiable.


2021 ◽  
Vol 45 ◽  
Author(s):  
Odewumi Adegbija ◽  
Jacina Walker ◽  
Nicholas Smoll ◽  
Arifuzzaman Khan ◽  
Julieanne Graham ◽  
...  

The implementation of public health measures to control the current COVID-19 pandemic (such as wider lockdowns, overseas travel restrictions and physical distancing) is likely to have affected the spread of other notifiable diseases. This is a descriptive report of communicable disease surveillance in Central Queensland (CQ) for six months (1 April to 30 September 2020) after the introduction of physical distancing and wider lockdown measures in Queensland. The counts of notifiable communicable diseases in CQ in the six months were observed and compared with the average for the same months during the years 2015 to 2019. During the study’s six months, there were notable decreases in notifications of most vaccine-preventable diseases such as influenza, pertussis and rotavirus. Conversely, notifications increased for disease groups such as blood-borne viruses, sexually transmitted infections and vector-borne diseases. There were no reported notifications for dengue fever and malaria which are mostly overseas acquired. The notifications of some communicable diseases in CQ were variably affected and the changes correlated with the implementation of the COVID-19 public health measures.


2021 ◽  
Vol 45 ◽  
Author(s):  
Monica M Lahra ◽  
CR Robert George ◽  
Masoud Shoushtari ◽  
Tiffany R Hogan

Invasive meningococcal disease (IMD) is a notifiable disease in Australia, and both probable and laboratory-confirmed cases of IMD are reported to the National Notifiable Diseases Surveillance System (NNDSS). In 2020, there were 90 notifications of IMD, the lowest number documented since records began in the NNDSS in 1991. Of these, 97% (87/90) were laboratory-confirmed cases, with 70% (61/87) confirmed by bacterial culture and 30% (26/87) by nucleic acid amplification testing. The serogroup was determined for 85/87 laboratory-confirmed cases of IMD: serogroup B (MenB) accounted for 64% of infections (54/85); MenW for 19% (16/85); MenY for 16% (14/85); and MenC 1.2% (1/85). Fine typing was available on 60/85 (71%) of cases with serogroup determined; of the typed MenW, all were PorA antigen type P1.5,2 and sequence type 11, the hypervirulent strain reported in recent outbreaks in Australia and overseas. The primary peaks of IMD notifications in Australia in 2020 were observed in infants less than 1 year (16/87, 18%) and in adults aged 45–64 years (14/87, 16%). MenB infections predominated in those aged less than 5 years and 15–19 years; MenW and MenY infections predominated in those aged 45 years or more. All 61 IMD isolates were tested for antimicrobial susceptibility: none were penicillin resistant; however, 56/61 (92%) had decreased susceptibility to penicillin. All isolates were susceptible to ceftriaxone, ciprofloxacin and rifampicin.


Author(s):  
Katrine M. Paulsen ◽  
Rose Vikse ◽  
Arnulf Soleng ◽  
Kristin Edgar ◽  
Heidi Elisabeth Heggen Lindstedt ◽  
...  

In Norway, tick-borne encephalitis (TBE) has been a mandatory notifiable disease since 1975 (Norwegian Surveillance system for communicable diseases, MSIS).1 According to ECDCs classification, coastal areas in southern Norway (counties of Agder, and Vestfold and Telemark) are endemic for TBE. Further, Viken County (former Østfold, Akershus and Buskerud), and western and northern Norway to Brønnøy municipality is imperiled.2-9


2020 ◽  
Vol 44 ◽  
Author(s):  
Monica M Lahra ◽  
Tiffany R Hogan

Invasive meningococcal disease (IMD) is a notifiable disease in Australia, and both probable and laboratory-confirmed cases of IMD are reported to the National Notifiable Diseases Surveillance System (NNDSS). In 2019, there were 206 notifications of IMD. Of these, 202 were laboratory-confirmed cases analysed by the reference laboratories of the Australian National Neisseria Network (NNN). Of the 202 laboratory-confirmed cases of IMD, 167 were confirmed by bacterial culture and 35 by nucleic acid amplification testing, and all had the serogroup determined. Fine typing was available on 146 samples (146/202, 72%). Neisseria meningitidis serogroup B (MenB) infections accounted for 50.0% (101/202); MenW for 26.2% (53/202); MenY for 20.8% (42/202) and MenC for 3.0% of cases (6/202). Of the MenW cases, 88% were PorA antigen type P1.5,2, and 65% of these (24/37) were sequence type 11, the hypervirulent strain reported in recent outbreaks in Australia and overseas. The primary peaks of IMD notifications in Australia in 2019 were observed in infants less than 1 year of age (36/202, 18%) and in adults aged 65 years or older (39/202, 19%). MenB infections predominated in those aged less than 5 years and those aged 15–19 years, whereas MenW and MenY infections predominated in those aged 45 years or more. All 167 IMD isolates were tested for antimicrobial susceptibility. One isolate out of these 167 (0.6%) was resistant to penicillin with an MIC ≥ 1mg/L; 154/167 isolates (92%) had decreased susceptibility to penicillin. All isolates were susceptible to ceftriaxone and ciprofloxacin, and one isolate was resistant to rifampicin.


2015 ◽  
Vol 7 (1) ◽  
Author(s):  
Anna Grigoryan

The purpose of this study was to identify ideas for an enhanced dissemination of the US National Notifiable Diseases Surveillance System (NNDSS) provisional data. The author conducted a search of all US State Health Department websites looking for on-line data display tables and tools for either reportable or notifiable diseases. In addition, the scope of the search of websites was expanded to include notifiable diseases of several countries, organizations and institutions. As a result of this study the author proposes enhancement of the current US notifiable disease data display from a static format to a more interactive dashboard design.


2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Xiang Ren ◽  
Liping Wang ◽  
Benjamin J. Cowling ◽  
Lingjia Zeng ◽  
Mengjie Geng ◽  
...  

ObjectiveWe aimed to review the development and changes of National Notifiable Disease Surveillance System (NNDSS) from 1950 to 2013, and to analyze and summarize the changes in regulations and public health surveillance practices in China.IntroductionInfectious disease was the second most common cause of death in 1949, and the epidemic situation of infectious diseases was so severe that the Chinese government made major investments to the control and prevention of infectious diseases. During the past 60 years the development of the notifiable disease surveillance system in China has experienced 3 phases, including germination stage, development stage, improvement and consolidation stage (1). As the quality of infectious diseases surveillance has been improved stepwisely, the national morbidity of class A and B notifiable disease decreased from 7157.5 per 100,000 in 1970 to 225.8 per 100,000 in 2013, and the mortality decreased from 56.0 per 100,000 in 1959 to 1.2 per 100,000 in 2013(2).MethodsResearch articles, online reports and grey literature from January 1950 to February 2013 relevant to disease surveillance in China were searched in databases including PubMed, China National Knowledge Infrastructure (CNKI), and Wanfang Data. Retrieved articles were screened by inclusion criteria of containing the infectious diseases prevention and control, related laws and regulations, and development of surveillance system.ResultsIn the systematic review, 20 articles were retrieved from PubMed, 1129 articles from CNKI, 480 articles from WanFang database, after abstract screening and eliminating overlaps, 73 articles were included, including 10 English articles and 63 Chinese articles.Laws and regulations on notifiable diseases in ChinaAdministrative Measures for Infectious Diseases Control was issued in 1955 to deal with 18 diseases (classes A and B) for their notification, monitoring, reporting and treatment. In 1956, 7 more infectious diseases were added into class B infectious diseases. Regulation on the Administration of Acute Infectious Diseases was issued in 1978, infectious diseases in class A and B including suspected cases must be reported within specific time respectively. The Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, the first infectious disease law in China, was issued in 1989 and revised in 2004. The number of notifiable infectious diseases was increased to 35, including 2 class A, 21 class B and 12 class C notifiable diseases in 1989. The 2004 revised version contained total 37 notifiable diseases and clarified infectious disease prevention, epidemic situation report, notification and release, epidemic control, medical treatment, supervision and management, logistic measures, legal responsibility and supplementary provisions.The organization of notifiable disease surveillance and managementIn 1950s, the Government Administration Council approved the bill of the establishment of Health Epidemic Prevention Stations (HEPS) nationwide. Chinese Academy of Medical Sciences (CAMS) was established in 1956, and the Chinese Academy of Preventive Medicine (CAPM) was established in 1986, which was in charge of the national infectious disease surveillance data collection, management, analysis and feedback. In 2002, the CAPM officially changed its name to the Chinese Center for Disease Control and Prevention (CDC), so did all levels of health epidemic prevention station. As mentioned in the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, CDCs at all levels are responsible for infectious disease surveillance, prediction, epidemiological investigation, epidemic reporting and other prevention and control. In addition, the law clarified the establishment of infectious disease surveillance system, the specific duties and tasks of the administrative department of public health and healthcare technology institutions in the infectious disease surveillance (Figure 1).Notifiable diseases diagnostic criteria Notifiable Diseases Diagnostic Criteria (Trial Edition) was issued in 1990 and revised in 2004. Diagnostic Criteria defined suspected case, probable case and confirmed case. Suspected case mainly based on clinical symptoms and signs; probable case was the suspected cases with hemogram blood test. Confirmed case was based on blood test results and pathogen specific antigen or antibody test results, eg. Ig G, Ig M or virus tested positive among suspected or probable cases.Reporting method of notifiable diseases surveillance systemDuring 1950 to 1985, monthly collection of reports was delivered by post mail level by level hierarchically (from county HEPSs to prefectural or city HEPSs, then to provincial HEPSs and eventually to CAPM ). The notifiable infectious diseases reporting network covered the whole country firmly launched at the mid-1960s.In 1986, the prototype of electronic reporting was sprout. Over 200 network nodes achieved electronic submission of the national notifiable infectious diseases monthly report by post-delivery, some provinces even had adopted more efficient reporting means by e-mail autonomously. During 1986 to 2003, different reporting cards are used for collecting class A, B, and C infectious diseases respectively. At the beginning of each year, the provincial HEPSs updated the population census data and the administrative changes. At the end of each year, the provincial HEPSs reported detailed age-gender and occupation specific diseases morbidity and mortality data, as well as amended monthly reports for delay or missing, to CAPM.The internet-based timely reporting system was officially launched in 2004. China CDC built the notifiable infectious diseases and emergent public health event reporting system that covered all hospitals and medical institutes nationwide, which collected individual case data with unified reporting card. By 2013 the system with over 70,000 reporting units covered 100% county and above level CDCs, 98% of county and above level medical institutions, and 94% of township level healthcare units.ConclusionsMonthly reporting was replaced by real-time reporting, and the weekly, monthly and yearly cumulative incidence and death was replaced by individual case reporting. The hierarchical reporting structure, were changed to reporting directly to national data center. The notifiable disease surveillance system network has been expanded, the diagnosis capacity and criteria, surveillance data report methods and sensitivity have been improved gradually. The notifiable disease surveillance system optimized step by step with internet-based timely reporting technology and direct filling infectious disease case information from healthcare facilities.References1. Cheng M, etc. The history and development trend of disease surveillance in China. Disease Surveillance, 2005, 20(3): 113-114.2. The national health and family planning commission of the People's Republic of China. The national epidemic situation of notifiable diseases in 2012.


2016 ◽  
Vol 144 (15) ◽  
pp. 3263-3277 ◽  
Author(s):  
K. B. GIBNEY ◽  
A. C. CHENG ◽  
R. HALL ◽  
K. LEDER

SUMMARYWe reviewed the first 21 years (1991–2011) of Australia's National Notifiable Diseases Surveillance System (NNDSS). All nationally notified diseases (except HIV/AIDS and Creutzfeldt–Jakob disease) were analysed by disease group (n= 8), jurisdiction (six states and two territories), Indigenous status, age group and notification year. In total, 2 421 134 cases were analysed. The 10 diseases with highest notification incidence (chlamydial infection, campylobacteriosis, varicella zoster, hepatitis C, influenza, pertussis, salmonellosis, hepatitis B, gonococcal infection, and Ross River virus infection) comprised 88% of all notifications. Annual notification incidence was 591 cases/100 000, highest in the Northern Territory (2598/100 000) and in children aged <5 years (698/100 000). A total of 8·4% of cases were Indigenous Australians. Notification incidence increased by 6·4% per year (12% for sexually transmissible infections and 15% for vaccine-preventable diseases). The number of notifiable diseases also increased from 37 to 65. The number and incidence of notifications increased throughout the study period, partly due to addition of diseases to the NNDSS and increasing availability of sensitive diagnostic tests. The most commonly notified diseases require a range of public health responses addressing high-risk sexual and drug-use behaviours, food safety and immunization. Our results highlight populations with higher notification incidence that might require tailored public health interventions.


Sign in / Sign up

Export Citation Format

Share Document